Virological Suppression in People With HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar Across Age Groups Despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)

Conference Reports for NATAP

ID Week
Oct 11-15 2023
Boston, MA


Virological Suppression in People With HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar Across Age Groups Despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)

	ID Week Oct 11 2023